P. LoRusso
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
-
- Advanced Breast Cancer Therapies
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 15
- Cancer Treatment and Pharmacology 6
- HER2/EGFR in Cancer Research 6
- Colorectal Cancer Treatments and Studies 5
- Cancer Immunotherapy and Biomarkers 2
- CAR-T cell therapy research 2
-
- Lung Cancer Treatments and Mutations 4
- Advanced Breast Cancer Therapies 3
- Co-authors
- Keith D. Wilner (2 shared papers)Sophia Randolph (2 shared papers)Peter J. O’Dwyer (1 shared paper)Mark A. Dickson (1 shared paper)Gary K. Schwartz (1 shared paper)Ronan Courtney (1 shared paper)M. Naveed Shaik (1 shared paper)Geoffrey I. Shapiro (3 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Annals of Oncology (5 papers)European Journal of Cancer (2 papers)Investigational New Drugs (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesBelgiumSpain
In The Last Decade
P. LoRusso
21 papers receiving 505 citations
Peers
Comparison fields: 5 of 45
- Oncology 264
- Pulmonary and Respiratory Medicine 288
- Genetics 60
- Cancer Research 58
- Molecular Biology 177
Countries citing papers authored by P. LoRusso
This map shows the geographic impact of P. LoRusso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. LoRusso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. LoRusso more than expected).
Fields of papers citing papers by P. LoRusso
This network shows the impact of papers produced by P. LoRusso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. LoRusso. The network helps show where P. LoRusso may publish in the future.
Co-authors
The 25 scholars most cited alongside P. LoRusso, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 223 | |
| 2 | 2011 | 102 | |
| 3 | 2010 | 45 | |
| 4 | 2011 | 40 | |
| 5 | 2012 | 30 | |
| 6 | 1997 | 13 | |
| 7 | 2007 | 12 | |
| 8 | 2021 | 11 | |
| 9 | 2014 | 10 | |
| 10 | Small-Molecule Tyrosine Kinase Inhibitors | 2008 | 8 |
| 11 | Pharmacokinetics of orally administered rucaparib in patients with advanced solid tumors. | 2013 | 3 |
| 12 | 2007 | 3 | |
| 13 | 2019 | 3 | |
| 14 | 2011 | 3 | |
| 15 | 2019 | 1 | |
| 16 | 2022 | 1 | |
| 17 | 2020 | 1 | |
| 18 | 2011 | 1 | |
| 19 | 2010 | 1 | |
| 20 | 2001 | 1 |
About P. LoRusso
P. LoRusso is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Immunology and Organic Chemistry, having authored 21 papers that have together received 513 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (6 papers), HER2/EGFR in Cancer Research (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Lung Cancer Treatments and Mutations (4 papers), Advanced Breast Cancer Therapies (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Oncology (264 citations), Pulmonary and Respiratory Medicine (288 citations), Genetics (60 citations), Cancer Research (58 citations) and Molecular Biology (177 citations). P. LoRusso has collaborated with scholars based in United States, Belgium and Spain. Frequent co-authors include Keith D. Wilner, Sophia Randolph, Peter J. O’Dwyer, Mark A. Dickson, Gary K. Schwartz, Ronan Courtney, M. Naveed Shaik, Geoffrey I. Shapiro, Scott A. Boerner and Benjamin Solomon. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Investigational New Drugs and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.